Home > Browse Reports > > Cardiac Rhythm Management Devices World Markets: Defibrillators, Pacemakers and Leads

Report Description

Cardiac Rhythm Management Devices World Markets: Defibrillators, Pacemakers and Leads
Publication Date: 04-MAY-04
Pages: 188
Study: TMRCAR
Format/Price: PDF document / $999.00
   


Description:



This TriMark Publications report reviews the worldwide cardiac rhythm management market size for the U.S., European and Asian markets. Individual country markets such as Japan, the Philippines, Australia, and the Middle East are covered. Important regulatory issues that impact the use of cardiac rhythm devices are explored for countries like the U.S., Japan, Australian, Korea, India, China, Israel, the Philippines, and those in the E.U. Reimbursement strategies for the U.S. Medicare program and European and Japanese medical insurance programs are discussed. Also, a summary of current legal proceedings in this industry, which are often used for competitive purposes, is provided. It focuses sales and market trends for pacemakers, defibrillators, leads, and other related cardiac rhythm devices. The cardiac rhythm management markets are divided into the segments of: external defibrillators, implantable defibrillators, external pacemakers, implantable pacemakers, and defibrillator and pacemaker electrodes and leads heart failure specialty products.





Table of Contents:

  1. 1.0 Executive Summary 8
  2. 1.1 Methodology 11
  3. 1.2 Overview of Report Objectives 11
  4. 2.0 Medical Device Market Overview 13
  5. 2.1.1 U.S. Medical Device Industry 13
  6. 2.1.2 China 17
  7. 2.1.3 Hong Kong 18
  8. 2.1.4 Taiwan 18
  9. 2.1.5 Singapore 18
  10. 2.1.6 Japan 18
  11. 2.1.7 Canadian Medical Device Market 18
  12. 2.1.8 European Medical Device Market 19
  13. 2.1.9 U.S. Cardiac Rhythm Management Market 21
  14. 2.1.10 European Market 23
  15. 2.1.11 Asian Market 24
  16. 2.1.11.1 Japanese Market Overview 24
  17. 2.1.11.2 Japanese Medical Practice 28
  18. 2.1.11.3 Japanese Distribution/Business Practices 28
  19. 2.1.11.4 Japanese Pricing 28
  20. 2.1.11.5 The Philippines Market 30
  21. 2.1.12 Australian Market 30
  22. 2.1.13 Middle Eastern Market 31
  23. 2.2 Cardiovascular Conditions Treated with Defibrillation and/or Pacing Devices 31
  24. 2.2.1 Cardiac Rhythm Management 32
  25. 2.2.2 Conditions Treated 32
  26. 2.2.2.1 Bradycardia 33
  27. 2.2.2.2 Tachyarrhythmia 34
  28. 2.2.2.3 Heart Failure 36
  29. 2.2.2.4 Atrial Fibrillation 36
  30. 2.3 Principal Products 37
  31. 2.3.1 Implantable Cardiac Rhythm Devices for Bradycardia 38
  32. 2.3.1.1 Single-Chamber Pacemakers 38
  33. 2.3.1.1.1 Non-Rate Responsive Devices 38
  34. 2.3.1.1.2 Rate Responsive Devices 38
  35. 2.3.2 Dual-Chamber Pacemakers 38
  36. 2.3.3 Pacemakers by Manufacturer 39
  37. 2.3.3.1 ELA Medical (Sorin/Sina) 39
  38. 2.3.3.2 Guidant 39
  39. 2.3.3.3 Medtronic 40
  40. 2.3.3.4 St. Jude Medical 40
  41. 2.3.3.5 CCC Del Uruguay SA 40
  42. 2.3.3.6 Fiab Spa (Italy) 40
  43. 2.3.3.7 NeuroCor 40
  44. 2.3.3.8 Pace Medical Inc. 40
  45. 2.3.4 Implantable Cardiac Rhythm Devices for Tachycardia 41
  46. 2.3.4.1 Tachyarrhythmia Devices 41
  47. 2.3.4.2 Biotronik 42
  48. 2.3.4.3 ELA Medical 42
  49. 2.3.4.4 Guidant 42
  50. 2.3.4.5 Medtronic 44
  51. 2.3.4.6 St. Jude Medical 44
  52. 2.3.4.7 Defibrillators Growth Drivers 44
  53. 2.3.4.8 Factors Limiting the Growth of Defibrillators 44
  54. 2.3.5 Implantable Cardiac Rhythm Devices for Heart Failure 44
  55. 2.3.6 External Products 45
  56. 2.3.6.1 Defibrillators 45
  57. 2.3.6.2 Transesophageal Pacing 46
  58. 2.3.7 Product Innovations 47
  59. 2.3.7.1 Miniaturization 47
  60. 2.3.7.2 Modular Designs 47
  61. 2.3.7.3 New Products 47
  62. 2.4 Patient Management 48
  63. 2.5 Regulatory Issues - Government Regulation 48
  64. 2.5.1 U.S. Regulation 48
  65. 2.5.1.1 Importing Medical Devices into the U.S. 51
  66. 2.5.1.2 Exporting Medical Devices from the U.S. 52
  67. 2.5.2 U.K. Regulation 52
  68. 2.5.3 EU Regulation 54
  69. 2.5.4 Japanese Regulation 55
  70. 2.5.5 Australian Regulation 56
  71. 2.5.6 Korea Regulation 57
  72. 2.5.7 India Regulation 57
  73. 2.5.8 Registration for Imported Medical Devices in China 58
  74. 2.5.9 Israel 58
  75. 2.5.10 The Philippines 58
  76. 2.5.11 Overseas Testing to Increase Time-to-Market 58
  77. 2.6 Guidelines and Trade Organizations 59
  78. 2.6.1 American Heart Association (AHA) 59
  79. 2.6.2 Health Industry Manufacturers Association (HIMA) 59
  80. 2.7 Other Factors Influencing Cardiac Rhythm Management Devices 59
  81. 2.8 Worldwide Developments 60
  82. 2.9 Reimbursement 60
  83. 2.9.1 U.S. Reimbursement 60
  84. 2.9.1.1 Category "C" Codes 61
  85. 2.9.1.2 Medicare Decision on MADIT Reimbursements 61
  86. 2.9.2 European Reimbursement 62
  87. 2.9.3 Japanese Reimbursement 62
  88. 2.10 Legal Proceedings 63
  89. 2.11 Competition 68
  90. 2.12 Strategic Corporate Developments 69
  91. 2.12.1 Acquisitions 69
  92. 2.12.2 Partnerships 71
  93. 2.13.3 Other Developments 71
  94. 2.13.4 Product Launches 71
  95. 3.0 The External Defibrillator Market 74
  96. 3.1 Defibrillators Overview 74
  97. 3.2 External Automated Defibrillators 74
  98. 3.3 Analysis of Major Competitors 78
  99. 4.0 The Implantable Defibrillator Market 83
  100. 4.1 Overview 83
  101. 4.1.1 Market Drivers for ICDs 83
  102. 4.2 The Worldwide Market 85
  103. 4.3 The U.S. Market 86
  104. 4.4 Japanese Market 87
  105. 4.5 Analysis of Major Competitors 87
  106. 4.5.1 Biotronik 89
  107. 4.5.2 Guidant Corporation 89
  108. 4.5.3 Medtronic 90
  109. 4.5.4 St. Jude Medical 92
  110. 4.5.5 ELA Medical 92
  111. 4.5.6 Japan Lifeline (JLL) 93
  112. 4.5.7 Cardiac Rhythm Management 93
  113. 5.0 The External Pacemakers Market 94
  114. 5.1 Overview 94
  115. 5.2 The U.S. Market 94
  116. 5.3 The Worldwide Market 95
  117. 5.4 Analysis of Major Competitors 96
  118. 5.5 Transvenous External Pacemakers 97
  119. 5.6 Transvenous Pacemakers' Development 97
  120. 6.0 The Implantable Pacemakers Market 98
  121. 6.1 Overview 98
  122. 6.2 The Worldwide Market 98
  123. 6.3 The U.S. Market 99
  124. 6.4 Analysis of Major Competitors 101
  125. 6.5 Transvenous Temporary Pacemakers 106
  126. 7.0 Market Overview 107
  127. 7.1.1 Defibrillator and Pacemaker Lead/Electrode Markets 107
  128. 7.1.2 Lead Extraction Market 108
  129. 7.1.3 Electrode Tips and Rings 108
  130. 7.2 The Worldwide Market 108
  131. 7.3 The U.S. Market 110
  132. 7.4 Analysis of Major Competitors 111
  133. 7.4.1 Cardiotronic 112
  134. 7.4.2 Guidant Corporation 112
  135. 7.4.3 Medtronic 112
  136. 7.4.4 St. Jude Medical 113
  137. 7.4.5 Zoll Medical 115
  138. 7.4.6 Biomec 115
  139. 7.4.7 ELA Medical 115
  140. 7.4.8 Sorin Biomedica 115
  141. 7.4.9 Biotronik 115
  142. 7.4.10 DR-ING P Osypka GmbH 115
  143. 7.4.11 CardioDynamics 116
  144. 8.0 Heart Failure Products 117
  145. 8.1 Overview 117
  146. 8.2 Heart Failure Conditions 118
  147. 8.3 Heart Failure Technology Platforms 118
  148. 8.4 Patient Management through the Internet 120
  149. 9.0 Company Profiles 121
  150. 9.1 Cardiac Science Inc. 121
  151. 9.2 Ballard Medical Products (Cardiotronic Systems Inc.) Kimberly-Clarke 123
  152. 9.3 Guidant Corporation 125
  153. 9.4 HeartBeat Medical Corporation 129
  154. 9.5 Medtronic Inc. 130
  155. 9.6 Pace Medical Inc. 134
  156. 9.7 St. Jude Medical, Inc. 137
  157. 9.8 Zoll Medical Corporation 141
  158. 9.9 General Electric Corporation Medical Division 144
  159. 9.10 Koninklijke Philips Electronics 145
  160. 9.11 Thoratec Corporation 147
  161. 9.12 Biomec Inc. 151
  162. 9.13 ELA Medical 151
  163. 9.14 Sorin Biomedica/ELA 153
  164. 9.15 Biotronik 154
  165. 9.16 Japan Lifeline 155
  166. 9.17 Cook Vascular Inc. 155
  167. 9.18 Emtel 155
  168. 9.19 Heraeus 156
  169. 9.20 Mayo Healthcare 156
  170. 9.21 VascoMed, GmbH 156
  171. 9.22 Oscor, GmbH 158
  172. 9.23 CardioDynamics International Corp. 159
  173. 9.24 Vermed 160
  174. 10.0 Industry Trends 161
  175. 11.0 Corporate Directory 163
  176. Appendix 1: Cardiac Rhythm CPT Codes for Medicare 165
  177. Appendix 2: New European Guideline for Defibrillator Implants 166
  178. Appendix 3: Cardiovascular Device Manufacturers Internet Links 167
  179. Appendix 4: Reimbursement CPT/APC Codes for Pacing Monitors 171
  180. Appendix 5: Frequently Asked Questions on Transesophageal Cardiology 172
  181. Appendix 6: Revision of Japanese Medical Device Approval Applications Classifications 176
  182. Appendix 7: Medical Device Regulatory Requirements for Australia 178
  183. Appendix 8: Regulation of Medical Devices in China 183
  184. Appendix 9: Chinese Laboratories Accredited by the State Drug Administration for Product Testing 187
  185. INDEX OF TABLES
  186. Table 1: Worldwide Medical Manufacturing, 2002 - 2010 13
  187. Table 2: U.S. Domestic Medical Device Exports (Except Ophthalmic) Annual, 1995 - 2000 14
  188. Table 3: U.S. Medical Equipment (Except Ophthalmic) Imports for Consumption Annual, 1995 - 2000 15
  189. Table 4: Surgical and Medical Instruments: U.S. Domestic Exports Annual, 1995 - 2000 16
  190. Table 5: Surgical and Medical Supplies: U.S. Imports For Consumption Annual, 1995 - 2000 17
  191. Table 6: Destinations of Canadian Medical Device Exports, 1998 - 2000 19
  192. Table 7: Summary of the Total U.S. Defibrillator Market, 2001 and 2008 20
  193. Table 8: Summary of the Total Worldwide Defibrillator Market, 2001 and 2008 20
  194. Table 9: Summary of the Total U.S. Pacemaker Market, 2001 and 2008 20
  195. Table 10: Summary of the Total Worldwide Pacemaker Market, 2001 and 2008 20
  196. Table 11: Summary of the Total U.S. and Worldwide Defibrillator and Pacemaker Market, 2001 and 2008 21
  197. Table 12: Estimated Number of Worldwide Patients with New Defibrillator or Pacemaker Implants, 2001 21
  198. Table 13: Estimated Number of U.S. Patients with New Defibrillator and Pacemaker Implants, 2002 22
  199. Table 14: Estimated Market Share of U.S. Defibrillator and Pacemaker Devices, 2001 22
  200. Table 15: The U.S. Pacemaker and Defibrillator Market Size, 2001 - 2008 23
  201. Table 16: Estimated Number of European Patients with New Defibrillator and Pacemaker Implants, 2002 23
  202. Table 17: The European Pacemaker and Defibrillator Market 23
  203. Table 18: Estimated Number of New Defibrillator and Pacemaker Implants for Europe, 2001 - 2008 24
  204. Table 19: Japanese Medical Equipment Market 25
  205. Table 20: Japanese Medical Equipment Market Estimated Import Market Share, 2002 26
  206. Table 21: Japanese Implantable Device Market, 1994 - 2008 26
  207. Table 22: Japanese Pacemaker and Defibrillator Market, 1994 - 2008 27
  208. Table 23: Estimated Number of New Defibrillator and Pacemaker Implants for Japan, 2001 - 2004 27
  209. Table 24: Country Medical Device Prices: Converted on the Purchasing-Power Parity Basis 29
  210. Table 25: Cardiac Management Activity Cost: Converted on the Purchasing-Power Parity Basis 30
  211. Table 26: Estimated Number of New Defibrillator and Pacemaker Implants for the Philippines, 2001 - 2004 30
  212. Table 27: Estimated Number of New Defibrillator and Pacemaker Implants for Australia 31
  213. Table 28: Population and Physician Statistics for Countries with Medical Devices 31
  214. Table 29: Types of Defibrillators 41
  215. Table 30: New Technological Developments in the ICDs Market 41
  216. Table 31: External Defibrillators 46
  217. Table 32: Seven-Year Summary of Low Risk Device Applications and Review Times, 1995 - 2001 60
  218. Table 33: Cardiac Rhythm Management Business, 2000-2002 69
  219. Table 34: U.S. External Defibrillator Market, 1990-2008 75
  220. Table 35: Estimated Worldwide External Defibrillator Market Share Standings, 2001 77
  221. Table 36A: Worldwide External Defibrillator Market, 1990-2008 77
  222. Table 36B: Royal Phillips Electronics U.S. External Defibrillator Home Market, 2000-2008 82
  223. Table 36C: Market Drivers for ICDs 83
  224. Table 37: Worldwide Implantable Defibrillator Market, 2000-2008 85
  225. Table 38: U.S. Implantable Defibrillator Market, 2000-2008 86
  226. Table 39: Estimated U.S. ICD Manufacturer Market Share, 2002 87
  227. Table 40: Estimated Worldwide ICD Manufacturer Market Share, 2002 87
  228. Table 41: Estimated Worldwide ICD Manufacturer Market Share, 2000-2002 87
  229. Table 42: ICD Share of the Cardiac Rhythm Management Business for Key Players 89
  230. Table 43: Estimated U.S. ICD Manufacturer Market Share, 2000-2002 89
  231. Table 44: U.S. External Pacemaker Market, 1990-2008 95
  232. Table 45: Worldwide External Pacemaker Manufacturer Market Share Standings, 2002 95
  233. Table 46: Worldwide External Pacemaker Market, 1990-2008 96
  234. Table 47: Worldwide Implantable Pacemaker Markets, 2000-2008 99
  235. Table 48: Worldwide Implantable Pacemaker Manufacturer Market Share Standings, 2002 99
  236. Table 49: U.S. Implantable Pacemaker Market, 2000-2008 100
  237. Table 50: U.S. Sales of Implantable Pacemakers by Device Type, 2002 100
  238. Table 51: U.S. Implantable Pacemaker Manufacturer Market Share Standings, 2002 100
  239. Table 52: U.S. Pacemaker Manufacturer Market Share, 2000-2002 101
  240. Table 53: Pacemaker Share of the Cardiac Rhythm Management Business for Key Players 102
  241. Table 54: U.S. Pacemaker Manufacturer Market Share, 2000-2002 102
  242. Table 55: Worldwide Defibrillator/Pacing Leads Market, 1990-2008 109
  243. Table 56: Worldwide External Defibrillator Electrode Market, 1990-2008 109
  244. Table 57: Worldwide External Defibrillator Electrode Manufacturer Market Share Standings, 2002 110
  245. Table 58: U.S. Defibrillator/Pacing Leads Market, 1990-2008 110
  246. Table 59: U.S. External Defibrillator Electrode Market, 1990-2008 111
  247. Table 60A: U.S. Defibrillator and Pacing Lead Manufacturer Market Share Standings, 2002 111
  248. Table 60B: AV Nodal Ablation Procedures for AF in the U.S. 114
  249. Table 61: Guidant Financials ($ Thousands) 125
  250. Table 62A: Guidant Cardiac Rhythm Net Sales 126
  251. Table 62B: Guidant Business Unit Sales Share 126
  252. Table 63: Medtronic Five Year Sales Summary 131
  253. Table 64: Medtronic Consolidated Net Sales 2003 131
  254. Table 65: Medtronic Cardiac Rhythm Net Sales 131
  255. Table 66: St. Jude Medical Financials, 2002 138
  256. Table 67: St. Jude Sales by Division 138
  257. Table 68: St. Jude Medical Net Sales by Geographic Markets 138
  258. Table 69: St. Jude Cardiac Rhythm Net Sales 139
  259. Table 70: Japan Lifeline Ltd. Ownership 155
  260. Table 71: Vasco Pacing Leads 157
  261. INDEX OF FIGURES
  262. Figure 1: Comparison of Global Medical Technology Markets 19
  263. Figure 2: Global Cardiac Rhythm Market 21
  264. Figure 3: Worldwide Implantable Defibrillator Market 85
  265. Figure 4: Worldwide ICD Manufacturer Market Share 2002 88
  266. Figure 5: Cardiac Rhythm Management Business: 2000, 2001 and 2002 88
  267. Figure 6: Medtronic Net Sales, 2001, 2002 104
  268. Figure 7: Cardiac Rhythm Management Net Sales 132
  269. Figure 8: Cardiac Impedance Cardiography Equipment Market Share by Location of Use 160
  270. Figure 9: Cardiac Sensors Market Share by Location of Usage 160

Registration
Browse Reports
Search TriMark
Reading Room
My Account
View Cart
Home  |  Reports  |  Database Tables  |  Conferences  |  Contact Us  
     © 2008 TriMark Publications, LLC. All rights reserved.